Share on StockTwits

Investment analysts at Piper Jaffray assumed coverage on shares of Intersect ENT (NASDAQ:XENT) in a note issued to investors on Monday. The firm set an “overweight” rating on the stock.

Shares of Intersect ENT (NASDAQ:XENT) opened at 15.05 on Monday. Intersect ENT has a one year low of $12.02 and a one year high of $15.77. The stock’s 50-day moving average is $13.24 and its 200-day moving average is $13.24. The company’s market cap is $338.6 million.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.